Sign in

CIK 0001411685

  • Non-accelerated filer
  • Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
Operating
EIN
205093315
Phone
+1 650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-09 Cunningham Ann Michelle Director Grant or award · Non-Qualified Stock Option (right to buy) +17,600 17,600
2024-09-06 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +14,100 14,100
2024-03-04 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2022-03-01 Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-05-01 Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER Grant or award · Stock Option (Right to Buy) +300,000 300,000
2020-12-30 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2020-04-23 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2019-10-21 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2019-05-23 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2019-01-10 Cunningham Ann Michelle Director Grant or award · Stock Option (Right to Buy) +25,000 25,000

Page 1 of 1 · 10 trades